Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR-578/EPSTI1 axis.

Zeng, Xuehui; Zheng, Qingqi; Wang, Lang; Chen, Tao; Lin, Wenxin; Lin, Quanyang

Zeng, Xuehui; Zheng, Qingqi; Wang, Lang; Chen, Tao; Lin, Wenxin; Lin, Quanyang.

Affiliation

Zeng X; Department of Anesthesiology, Zhongshan Hospital Xiamen University, Xiamen City, China.
Zheng Q; Department of Anesthesiology, Zhongshan Hospital Xiamen University, Xiamen City, China.
Wang L; Department of Anesthesiology, Zhongshan Hospital Xiamen University, Xiamen City, China.
Chen T; Department of Anesthesiology, Zhongshan Hospital Xiamen University, Xiamen City, China.
Lin W; Department of Anesthesiology, Zhongshan Hospital Xiamen University, Xiamen City, China.
Lin Q; Department of Anesthesiology, Zhongshan Hospital Xiamen University, Xiamen City, China.

Thorac Cancer ; 14(26): 2665-2677, 2023 09.

Article in En | MEDLINE | ID: mdl-37533139

Subject(s)

Breast Neoplasms; MicroRNAs; Humans; Animals; Female; Breast Neoplasms/drug therapy; Breast Neoplasms/genetics; Sevoflurane/pharmacology; Apoptosis; Cell Count; Cell Proliferation; Disease Models, Animal; MicroRNAs/genetics; Neoplasm Proteins

Key words

EPSTI1; breast cancer; circ_0000129; miR-578; sevoflurane

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / MicroRNAs Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Thorac Cancer Year: 2023 Document type: Article Affiliation country: China Country of publication: Singapore

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google